Title | Type | SJR | H index | Total Docs. (2006) | Total Docs. (3years) | Total Refs. (2006) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2006) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Annual Review of Pharmacology and Toxicology | journal | 9.892 Q1 | 224 | 17 | 77 | 2900 | 1854 | 77 | 25.96 | 170.59 | |
2 | Pharmacological Reviews | journal | 8.345 Q1 | 254 | 37 | 80 | 8836 | 1662 | 77 | 18.65 | 238.81 | |
3 | Trends in Pharmacological Sciences | journal | 4.402 Q1 | 244 | 104 | 356 | 5460 | 3669 | 324 | 10.55 | 52.50 | |
4 | Pharmacology and Therapeutics | journal | 4.180 Q1 | 233 | 134 | 202 | 30111 | 2026 | 198 | 9.52 | 224.71 | |
5 | Reviews of Physiology Biochemistry and Pharmacology | journal | 6.223 Q1 | 70 | 8 | 44 | 1340 | 537 | 44 | 8.71 | 167.50 | |
6 | Medicinal Research Reviews | journal | 2.620 Q1 | 150 | 24 | 83 | 4024 | 781 | 83 | 8.69 | 167.67 | |
7 | Advanced Drug Delivery Reviews | journal | 2.778 Q1 | 366 | 107 | 365 | 10459 | 3360 | 303 | 8.61 | 97.75 | |
8 | Natural Product Reports | journal | 2.753 Q1 | 211 | 53 | 128 | 9245 | 950 | 123 | 7.73 | 174.43 | |
9 | Current Opinion in Pharmacology | journal | 2.803 Q1 | 148 | 98 | 308 | 4299 | 2098 | 279 | 7.45 | 43.87 | |
10 | Clinical Pharmacology and Therapeutics | journal | 2.412 Q1 | 209 | 137 | 418 | 4908 | 2940 | 325 | 7.30 | 35.82 | |
11 | Pharmacogenetics and Genomics | journal | 1.994 | 152 | 101 | 305 | 3820 | 2094 | 296 | 7.19 | 37.82 | |
12 | Current Drug Metabolism | journal | 1.835 Q1 | 122 | 65 | 123 | 7593 | 861 | 117 | 6.92 | 116.82 | |
13 | Current Cancer Drug Targets | journal | 2.656 Q1 | 103 | 44 | 141 | 7238 | 990 | 136 | 6.36 | 164.50 | |
14 | Neuropsychopharmacology | journal | 2.724 Q1 | 249 | 285 | 762 | 16343 | 4804 | 734 | 6.33 | 57.34 | |
15 | Drug Resistance Updates | journal | 2.412 Q1 | 132 | 19 | 92 | 2342 | 577 | 86 | 6.31 | 123.26 | |
16 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.719 Q1 | 82 | 13 | 36 | 1808 | 256 | 36 | 6.26 | 139.08 | |
17 | Journal of Medicinal Chemistry | journal | 1.919 Q1 | 301 | 866 | 2233 | 35928 | 13633 | 2232 | 6.07 | 41.49 | |
18 | Neurotherapeutics | journal | 1.932 Q1 | 136 | 53 | 109 | 4821 | 655 | 98 | 6.01 | 90.96 | |
19 | Molecular Therapy | journal | 2.219 Q1 | 209 | 228 | 724 | 9585 | 3951 | 649 | 5.68 | 42.04 | |
20 | Pain | journal | 2.495 Q1 | 296 | 292 | 1010 | 10938 | 6180 | 899 | 5.61 | 37.46 | |
21 | Drug Metabolism Reviews | journal | 1.571 Q1 | 108 | 46 | 88 | 3653 | 517 | 87 | 5.60 | 79.41 | |
22 | Current Medicinal Chemistry | journal | 1.847 Q1 | 202 | 249 | 597 | 33893 | 3484 | 562 | 5.59 | 136.12 | |
23 | Current Pharmaceutical Design | journal | 1.801 Q1 | 183 | 390 | 915 | 45398 | 4967 | 805 | 5.58 | 116.41 | |
24 | Nature Reviews Drug Discovery | journal | 7.332 Q1 | 391 | 162 | 916 | 7271 | 5779 | 265 | 5.58 | 44.88 | |
25 | Current Opinion in Drug Discovery and Development | journal | 1.404 Q1 | 85 | 67 | 245 | 3875 | 1246 | 229 | 5.43 | 57.84 | |
26 | Clinical Pharmacokinetics | journal | 1.534 Q1 | 184 | 82 | 241 | 5255 | 1530 | 238 | 5.41 | 64.09 | |
27 | Molecular Pharmacology | journal | 2.548 Q1 | 210 | 457 | 1136 | 17805 | 6452 | 1133 | 5.41 | 38.96 | |
28 | Journal of Molecular Medicine | journal | 2.697 Q1 | 157 | 116 | 311 | 5708 | 1685 | 293 | 5.31 | 49.21 | |
29 | Topics in antiviral medicine | journal | 2.279 Q1 | 46 | 22 | 63 | 163 | 281 | 63 | 5.31 | 7.41 | |
30 | Particle and Fibre Toxicology | journal | 1.458 Q1 | 119 | 16 | 14 | 852 | 74 | 13 | 5.29 | 53.25 | |
31 | Cell Chemical Biology | journal | 2.616 Q1 | 206 | 167 | 562 | 6085 | 2893 | 529 | 5.13 | 36.44 | |
32 | Cellular and Molecular Life Sciences | journal | 2.857 Q1 | 261 | 258 | 782 | 24555 | 4185 | 776 | 5.10 | 95.17 | |
33 | Journal of Immunotherapy | journal | 1.724 Q1 | 106 | 63 | 159 | 2851 | 753 | 153 | 5.01 | 45.25 | |
34 | Antimicrobial Agents and Chemotherapy | journal | 2.339 Q1 | 289 | 714 | 2401 | 20925 | 11741 | 2303 | 4.78 | 29.31 | |
35 | Pharmacogenomics Journal | journal | 1.357 Q1 | 95 | 54 | 158 | 2304 | 673 | 139 | 4.74 | 42.67 | |
36 | CNS and Neurological Disorders - Drug Targets | journal | 1.820 Q1 | 96 | 55 | 146 | 8234 | 703 | 136 | 4.64 | 149.71 | |
37 | Journal of Pharmacology and Experimental Therapeutics | journal | 1.706 Q1 | 244 | 649 | 1851 | 24271 | 9068 | 1847 | 4.57 | 37.40 | |
38 | Drug Safety | journal | 1.352 Q1 | 140 | 93 | 262 | 5283 | 1202 | 245 | 4.54 | 56.81 | |
39 | Current Gene Therapy | journal | 1.267 Q1 | 80 | 46 | 138 | 6424 | 615 | 134 | 4.49 | 139.65 | |
40 | Journal of Controlled Release | journal | 1.788 Q1 | 313 | 340 | 996 | 11303 | 4961 | 992 | 4.47 | 33.24 | |
41 | Antiviral Therapy | journal | 1.790 Q1 | 93 | 126 | 326 | 4438 | 1413 | 312 | 4.46 | 35.22 | |
42 | Drug Metabolism and Disposition | journal | 1.490 Q1 | 194 | 281 | 683 | 8936 | 3360 | 672 | 4.44 | 31.80 | |
43 | Bioconjugate Chemistry | journal | 1.720 Q1 | 192 | 211 | 560 | 7343 | 2597 | 556 | 4.41 | 34.80 | |
44 | Current Drug Targets | journal | 1.512 Q1 | 119 | 161 | 224 | 19288 | 997 | 205 | 4.41 | 119.80 | |
45 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 1.205 Q1 | 50 | 10 | 17 | 1137 | 75 | 17 | 4.41 | 113.70 | |
46 | Neuropharmacology | journal | 1.921 Q1 | 191 | 229 | 730 | 10800 | 3166 | 727 | 4.37 | 47.16 | |
47 | Journal of Nanobiotechnology | journal | 1.124 Q1 | 109 | 14 | 27 | 465 | 106 | 27 | 4.33 | 33.21 | |
48 | Toxicology and Applied Pharmacology | journal | 1.398 Q1 | 189 | 273 | 803 | 12287 | 3410 | 788 | 4.32 | 45.01 | |
49 | Controlled Clinical Trials | journal | 1.648 Q1 | 76 | 0 | 117 | 0 | 406 | 106 | 4.30 | 0.00 | |
50 | Current Topics in Medicinal Chemistry | journal | 1.554 Q1 | 133 | 151 | 369 | 15275 | 1773 | 328 | 4.28 | 101.16 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®